[go: up one dir, main page]

AU2001262996A1 - Malaria vaccine and methods thereof based upon novel antigenic domain of plasmodium falciparum - Google Patents

Malaria vaccine and methods thereof based upon novel antigenic domain of plasmodium falciparum

Info

Publication number
AU2001262996A1
AU2001262996A1 AU2001262996A AU6299601A AU2001262996A1 AU 2001262996 A1 AU2001262996 A1 AU 2001262996A1 AU 2001262996 A AU2001262996 A AU 2001262996A AU 6299601 A AU6299601 A AU 6299601A AU 2001262996 A1 AU2001262996 A1 AU 2001262996A1
Authority
AU
Australia
Prior art keywords
methods
plasmodium falciparum
malaria vaccine
antigenic domain
novel antigenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001262996A
Inventor
Eugene Davidson
David Nikodem
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Georgetown University
Original Assignee
Georgetown University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Georgetown University filed Critical Georgetown University
Publication of AU2001262996A1 publication Critical patent/AU2001262996A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • C07K16/205Plasmodium
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445Plasmodium
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/36011Togaviridae
    • C12N2770/36111Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
    • C12N2770/36141Use of virus, viral particle or viral elements as a vector
    • C12N2770/36143Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU2001262996A 2000-05-08 2001-05-08 Malaria vaccine and methods thereof based upon novel antigenic domain of plasmodium falciparum Abandoned AU2001262996A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20243000P 2000-05-08 2000-05-08
US60202430 2000-05-08
PCT/US2001/014716 WO2001085927A1 (en) 2000-05-08 2001-05-08 Malaria vaccine and methods thereof based upon novel antigenic domain of plasmodium falciparum

Publications (1)

Publication Number Publication Date
AU2001262996A1 true AU2001262996A1 (en) 2001-11-20

Family

ID=22749836

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001262996A Abandoned AU2001262996A1 (en) 2000-05-08 2001-05-08 Malaria vaccine and methods thereof based upon novel antigenic domain of plasmodium falciparum

Country Status (2)

Country Link
AU (1) AU2001262996A1 (en)
WO (1) WO2001085927A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10249390A1 (en) * 2002-10-23 2004-05-13 Ruprecht-Karls-Universität Heidelberg Recombinant MVA strains as potential vaccines against P. falciparum malaria
WO2004043399A2 (en) * 2002-11-13 2004-05-27 The United States Of America As Represented By The Secretary Of The Navy Methods and compositions for inducing immune responses and protective immunity by priming with alphavirus replicon vaccines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756101A (en) * 1991-07-01 1998-05-26 Pasteur Merieux Serums Et Vaccins Malaria recombinant poxvirus
US5541087A (en) * 1994-09-14 1996-07-30 Fuji Immunopharmaceuticals Corporation Expression and export technology of proteins as immunofusins
JP2000504223A (en) * 1996-01-29 2000-04-11 ジョージタウン・ユニヴァーシティ Malaria vaccine based on the addition of MSA1 peptide

Also Published As

Publication number Publication date
WO2001085927A1 (en) 2001-11-15

Similar Documents

Publication Publication Date Title
EP1309602A4 (en) Malaria immunogen and vaccine
IL151942A0 (en) Compositions and methods for enhancing immunogenicity of antigens
AU2001241918A1 (en) Methods of enhancing activity of vaccines and vaccine compositions
AU2003208986A1 (en) Inactivation of west nile virus and plasmodium falciparum using alloxazine-derivating photosensitizers
EP1569950B8 (en) Plasmodium falciparum antigens and methods of use
AU2002343321A1 (en) Isolation and purification of plasmodium falciparum merozoite protein-142
AU2002326751A1 (en) Immunoglobulin e vaccines and methods of use thereof
AU2002331791A1 (en) Methods of preparing improved water-soluble extracts containing antioxidants and uses thereof
AU2001292667A1 (en) Immunogenic composition of hepatitis c and methods of use thereof
AU2001295672A1 (en) Vaccine composition and stabilisation method
AU2001262996A1 (en) Malaria vaccine and methods thereof based upon novel antigenic domain of plasmodium falciparum
AU2002228347A1 (en) Malaria plasmodium antigen polypeptide SE36, method of purifying the same and vaccine and diagnostic with the use of the thus obtained antigen
AU2002361718A8 (en) Oxidized fungal antigens and methods of making and using thereof
AU2003291476A8 (en) Expression, purification and uses of a plasmodium falciparum liver stage antigen 1 polypeptide
AU2002347464A1 (en) Anti-arthropod vector vaccines methods of selecting and uses thereof
AU2002304480A1 (en) Plasmodium falciparum antigens and vaccine and diagnostic uses thereof
DE60220988D1 (en) PREPARATION AND USE OF A PLASMODIUM FUSIONANT
DK1697405T3 (en) LSA-5 liver stage and blood stage antigen from Plasmodium falciparum, immunogenic preparation comprising this antigen and vaccines against malaria
AU1762092A (en) Circumsporozoite protein of plasmodium reichenowi and vaccine for human malaria
HK1097277A (en) Lsa-5 liver stage and blood stage antigen of plasmodium falciparum, immunogenic composition comprising said antigen, and vaccines against malaria
AU2003281909A1 (en) Method of obtaining conjugate vaccines and vaccine compositions containing same
AU2002366708A8 (en) Preparation of vaccines using photosensitizer and light
AUPR020900A0 (en) Vaccines and methods of vaccination
AU2003210719A1 (en) Identification of mutant antigens with enhanced immunogenicity
AU2001261213A1 (en) Chemosensitizing agents against chloroquine resistant plasmodium falciparum and methods of making and using thereof